Aug 13, 2026 10:32AM
Jun 23, 2026 03:36AM
Jun 3, 2026 07:31AM
Jun 3, 2026 07:03AM
May 14, 2026 07:35AM
May 14, 2026 07:01AM
May 4, 2026 09:20AM Guggenheim on Cabaletta Bio (CABA): 'compelling evidence that CAR-T activity can be achieved without preconditioning'
May 4, 2026 06:37AM
Apr 29, 2026 07:25AM
Apr 1, 2026 06:58AM
Mar 27, 2026 10:55AM
Mar 23, 2026 09:08PM
Mar 23, 2026 04:57PM
Mar 23, 2026 04:44PM William Blair maintains Outperform rated on Cabaletta Bio Inc. (CABA) amid trial progress
Mar 23, 2026 01:54PM
Mar 23, 2026 01:53PM
Jan 27, 2026 07:09AM
Jan 16, 2026 07:10AM
Jan 12, 2026 08:10AM
Jan 12, 2026 07:31AM
Nov 10, 2025 07:42AM Cabaletta Bio, Inc. (CABA) Tops Q3 EPS by 3c
Oct 28, 2025 06:44AM
Oct 10, 2025 06:45AM
Oct 10, 2025 06:37AM
Oct 10, 2025 05:30AM
Sep 24, 2025 06:46AM
Aug 14, 2025 04:29PM
Aug 8, 2025 08:33AM Cabaletta Bio Inc. (CABA) PT Lowered to $15 at Guggenheim
Aug 7, 2025 04:52PM
Jun 27, 2025 11:31AM
Jun 13, 2025 07:03AM
Jun 12, 2025 08:13AM
Jun 11, 2025 09:56AM
Jun 11, 2025 06:15AM
Jun 11, 2025 06:01AM Cabaletta Bio (CABA) Announces New Rese-cel Safety and Efficacy Data
Apr 1, 2025 09:04AM
Mar 31, 2025 01:11PM
Feb 18, 2025 07:03AM
Jan 17, 2025 06:41AM
Nov 19, 2024 06:57AM
Nov 18, 2024 07:00AM
Nov 14, 2024 01:47PM Guggenheim Reiterates Buy Rating on Cabaletta Bio Inc. (CABA)
Oct 10, 2024 03:51AM
Sep 17, 2024 06:55AM
Aug 16, 2024 05:31AM
Aug 8, 2024 09:25AM
Jun 17, 2024 05:29AM

456,290 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All